{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:13:19Z","timestamp":1771650799633,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["GHTM \u2013 UID\/Multi\/04413\/2013"],"award-info":[{"award-number":["GHTM \u2013 UID\/Multi\/04413\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2281-x","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:49:12Z","timestamp":1522799352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum"],"prefix":"10.1186","volume":"17","author":[{"given":"Lis","family":"Lobo","sequence":"first","affiliation":[]},{"given":"L\u00edlia I. L.","family":"Cabral","sequence":"additional","affiliation":[]},{"given":"Maria In\u00eas","family":"Sena","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio Sebasti\u00e3o","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Valter Ferreira","family":"de Andrade-Neto","sequence":"additional","affiliation":[]},{"given":"Maria L. S.","family":"Cristiano","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-0778","authenticated-orcid":false,"given":"Fatima","family":"Nogueira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"2281_CR1","volume-title":"World Malaria report","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. World Malaria report. Geneva: World Health Organization; 2016."},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMp1108322","volume":"365","author":"AM Dondorp","year":"2011","unstructured":"Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, et al. The threat of artemisinin-resistant malaria. N Engl J Med. 2011;365:1073\u20135.","journal-title":"N Engl J Med"},{"key":"2281_CR3","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1086\/657120","volume":"51","author":"H Noedl","year":"2010","unstructured":"Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010;51:e82\u20139.","journal-title":"Clin Infect Dis"},{"key":"2281_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1475-2875-13-452","volume":"13","author":"Y Lubell","year":"2014","unstructured":"Lubell Y, Dondorp A, Gu\u00e9rin PJ, Drake T, Meek S, Ashley E, et al. Artemisinin resistance\u2014modelling the potential human and economic costs. Malar J. 2014;13:452.","journal-title":"Malar J."},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis."},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis."},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin\u2013piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683\u201391.","journal-title":"Lancet Infect Dis."},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"2281_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TNC Wells","year":"2015","unstructured":"Wells TNC, Hooft van Huijsduijnen R, Van Voorhis WC. Malaria medicines: a glass half full? Nat Rev Drug Discov. 2015;14:424\u201342.","journal-title":"Nat Rev Drug Discov."},{"key":"2281_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02779","volume":"430","author":"JL Vennerstrom","year":"2004","unstructured":"Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FCK, Chollet J, et al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature. 2004;430:900\u20134.","journal-title":"Nature"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cmdc.201402362","volume":"10","author":"SD Fontaine","year":"2015","unstructured":"Fontaine SD, Spangler B, Gut J, Lauterwasser EMW, Rosenthal PJ, Renslo AR. Drug delivery to the malaria parasite using an arterolane-like scaffold. ChemMedChem. 2015;10:47\u201351.","journal-title":"ChemMedChem"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/AAC.00574-16","volume":"60","author":"T Yang","year":"2016","unstructured":"Yang T, Xie SC, Cao P, Giannangelo C, McCaw J, Creek DJ, et al. Comparison of the exposure time dependence of the activities of synthetic ozonide antimalarials and dihydroartemisinin against K13 wild-type and mutant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2016;60:4501\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR14","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1128\/AAC.00857-16","volume":"60","author":"A Siriwardana","year":"2016","unstructured":"Siriwardana A, Iyengar K, Roepe PD. Endoperoxide drug cross-resistance patterns for Plasmodium falciparum exhibiting an artemisinin delayed-clearance phenotype. Antimicrob Agents Chemother. 2016;60:6952\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/mBio.00172-17","volume":"8","author":"J Straimer","year":"2017","unstructured":"Straimer J, Gn\u00e4dig NF, Stokes BH, Ehrenberger M, Crane AA, Fidock DA. Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro. MBio. 2017;8:2.","journal-title":"MBio."},{"issue":"7","key":"2281_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1590\/0074-02760160077","volume":"111","author":"L Lobo","year":"2016","unstructured":"Lobo L, de Sousa B, Cabral L, Cristiano MLS, Nogueira F. Highly active ozonides selected against drug resistant malaria. Mem Inst Oswaldo Cruz. 2016;111(7):450\u20133.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1128\/AAC.01305-09","volume":"54","author":"MA F\u00fcgi","year":"2010","unstructured":"F\u00fcgi MA, Wittlin S, Dong Y, Vennerstrom JL. Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals. Antimicrob Agents Chemother. 2010;54:1042\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejmech.2015.07.047","volume":"102","author":"SA Santos","year":"2015","unstructured":"Santos SA, Lukens AK, Coelho L, Nogueira F, Wirth DF, Mazitschek R, et al. Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype. Eur J Med Chem. 2015;102:320\u201333. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.047\n                    \n                   (Epub 2015 Jul 31).","journal-title":"Eur J Med Chem."},{"key":"2281_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.actatropica.2010.01.013","volume":"114","author":"F Nogueira","year":"2010","unstructured":"Nogueira F, Diez A, Radfar A, P\u00e9rez-Benavente S, do Rosario VE, Puyet A, et al. Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones. Acta Trop. 2010;114:109\u201315.","journal-title":"Acta Trop"},{"key":"2281_CR20","first-page":"1010","volume":"2","author":"M Machado","year":"2016","unstructured":"Machado M, Murtinheira F, Lobo ENF. Whole-Cell SYBR Green I assay for antimalarial activity assessment. Ann Clin Med Microbiol. 2016;2:1010.","journal-title":"Ann Clin Med Microbiol."},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis."},{"key":"2281_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-4894(65)90014-7","volume":"17","author":"W Peters","year":"1965","unstructured":"Peters W. Drug resistance in Plasmodium berghei Vincke and Lips, 1948. 3. Multiple drug resistance. Exp Parasitol. 1965;17:97\u2013102.","journal-title":"Exp Parasitol"},{"key":"2281_CR23","first-page":"1113","volume":"24","author":"LH Carvalho","year":"1991","unstructured":"Carvalho LH, Brand\u00e3o MG, Santos-Filho D, Lopes JL, Krettli AU. Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Plasmodium falciparum in culture. Brazilian J Med Biol Res. 1991;24:1113\u201323.","journal-title":"Brazilian J Med Biol Res."},{"key":"2281_CR24","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1128\/IAI.00079-10","volume":"78","author":"FG Baptista","year":"2010","unstructured":"Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigario AM. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun. 2010;78:4033\u20139.","journal-title":"Infect Immun"},{"key":"2281_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1055\/s-0031-1298333","volume":"78","author":"M Mota","year":"2012","unstructured":"Mota M, Lobo L, da Costa JG, Costa L, Rocha e Silva H, Rocha L, et al. In vitro and in vivo antimalarial activity of essential oils and chemical components from three medicinal plants found in northeastern Brazil. Planta Med. 2012;78:658\u201364.","journal-title":"Planta Med"},{"key":"2281_CR26","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.toxrep.2016.09.007","volume":"3","author":"VS de Sena Pereira","year":"2016","unstructured":"de Sena Pereira VS, Silva de Oliveira CB, Fumagalli F, Emery F, da Silva NB, de Andrade-Neto VF. Cytotoxicity, hemolysis and in vivo acute toxicity of 2-hydroxy-3-anilino-1,4-naphthoquinone derivatives. Toxicol Reports. 2016;3:756\u201362.","journal-title":"Toxicol Reports."},{"key":"2281_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1021\/jo502419u","volume":"80","author":"A Ismael","year":"2015","unstructured":"Ismael A, Borba A, Henriques MSC, Paix\u00e3o JA, Fausto R, Cristiano MLS. Structure and photochemistry of a saccharyl thiotetrazole. J Org Chem. 2015;80:392\u2013400.","journal-title":"J Org Chem"},{"key":"2281_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/med.10066","volume":"24","author":"Y Tang","year":"2004","unstructured":"Tang Y, Dong Y, Vennerstrom JL. Synthetic peroxides as antimalarials. Med Res Rev. 2004;24:425\u201348.","journal-title":"Med Res Rev"},{"key":"2281_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1021\/acsinfecdis.5b00090","volume":"2","author":"J Jourdan","year":"2016","unstructured":"Jourdan J, Matile H, Reift E, Biehlmaier O, Dong Y, Wang X, et al. Monoclonal antibodies that recognize the alkylation signature of antimalarial ozonides OZ277 (arterolane) and OZ439 (artefenomel). ACS Infect Dis. 2016;2:54\u201361.","journal-title":"ACS Infect Dis."},{"key":"2281_CR30","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1073\/pnas.1600459113","volume":"113","author":"HM Ismail","year":"2016","unstructured":"Ismail HM, Barton V, Phanchana M, Charoensutthivarakul S, Wong MHL, Hemingway J, et al. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proc Natl Acad Sci USA. 2016;113:2080\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2281_CR31","doi-asserted-by":"publisher","first-page":"e00172","DOI":"10.1128\/mBio.00172-17","volume":"8","author":"J Straimer","year":"2017","unstructured":"Straimer J, Gn\u00e4dig NF, Stokes BH, Ehrenberger M, Crane AA, Fidock DA. Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro. MBio. 2017;8:e00172\u2013217.","journal-title":"MBio."},{"key":"2281_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0378-8741(01)00346-4","volume":"78","author":"B Weniger","year":"2001","unstructured":"Weniger B, Robledo S, Arango GJ, Deharo E, Arag\u00f3n R, Mu\u00f1oz V, et al. Antiprotozoal activities of Colombian plants. J Ethnopharmacol. 2001;78:193\u2013200.","journal-title":"J Ethnopharmacol"},{"key":"2281_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jep.2007.08.012","volume":"114","author":"PN Soh","year":"2007","unstructured":"Soh PN, Benoit-Vical F. Are West African plants a source of future antimalarial drugs? J Ethnopharmacol. 2007;114:130\u201340.","journal-title":"J Ethnopharmacol"},{"key":"2281_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"S Nwaka","year":"2006","unstructured":"Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941\u201355.","journal-title":"Nat Rev Drug Discov."},{"key":"2281_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biopha.2015.04.003","volume":"72","author":"M Dr\u0105g-Zalesi\u0144ska","year":"2015","unstructured":"Dr\u0105g-Zalesi\u0144ska M, Wysocka T, Borska S, Dr\u0105g M, Por\u0119ba M, Choroma\u0144ska A, et al. The new esters derivatives of betulin and betulinic acid in epidermoid squamous carcinoma treatment\u2014in vitro studies. Biomed Pharmacother. 2015;72:91\u20137.","journal-title":"Biomed Pharmacother"},{"key":"2281_CR36","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/S0968-0896(02)00239-0","volume":"10","author":"RJ Herr","year":"2002","unstructured":"Herr RJ. 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. Bioorg Med Chem. 2002;10:3379\u201393.","journal-title":"Bioorg Med Chem"},{"key":"2281_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bioorg.2006.08.004","volume":"35","author":"X Fan","year":"2007","unstructured":"Fan X, Zhang X, Bories C, Loiseau PM, Torrence PF. The Ugi reaction in the generation of new nucleosides as potential antiviral and antileishmanial agents. Bioorg Chem. 2007;35:121\u201336.","journal-title":"Bioorg Chem"},{"key":"2281_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejmech.2004.03.004","volume":"39","author":"RS Upadhayaya","year":"2004","unstructured":"Upadhayaya RS, Jain S, Sinha N, Kishore N, Chandra R, Arora SK. Synthesis of novel substituted tetrazoles having antifungal activity. Eur J Med Chem. 2004;39:579\u201392.","journal-title":"Eur J Med Chem"},{"key":"2281_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ardp.200400967","volume":"338","author":"J Adamec","year":"2005","unstructured":"Adamec J, Waisser K, Kunes J, Kaustov\u00e1 J. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles. Arch Pharm (Weinheim). 2005;338:385\u20139.","journal-title":"Arch Pharm (Weinheim)"},{"key":"2281_CR40","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1016\/j.bmc.2011.08.039","volume":"19","author":"ES Schaffert","year":"2011","unstructured":"Schaffert ES, H\u00f6fner G, Wanner KT. Aminomethyltetrazoles as potential inhibitors of the \u03b3-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation. Bioorg Med Chem. 2011;19:6492\u2013504.","journal-title":"Bioorg Med Chem"},{"key":"2281_CR41","first-page":"31","volume":"2","author":"PB Mohite","year":"2012","unstructured":"Mohite PB, Bhaskar VH. In vitro evaluation of tetrazoles as a novel class of Antimycobacterium tuberculosis agents. Adv Pharm Bull. 2012;2:31\u20136.","journal-title":"Adv Pharm Bull."},{"key":"2281_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0079-6468(08)70159-0","volume":"17","author":"H Singh","year":"1980","unstructured":"Singh H, Chawla AS, Kapoor VK, Paul D, Malhotra RK. Medicinal chemistry of tetrazoles. Prog Med Chem. 1980;17:151\u201383.","journal-title":"Prog Med Chem"},{"key":"2281_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2478\/acph-2013-0018","volume":"63","author":"S Arulmurugan","year":"2013","unstructured":"Arulmurugan S, Kavitha HP. Synthesis and potential cytotoxic activity of some new benzoxazoles, imidazoles, benzimidazoles and tetrazoles. Acta Pharm. 2013;63:253\u201364.","journal-title":"Acta Pharm."},{"key":"2281_CR44","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1016\/j.bmcl.2014.07.061","volume":"24","author":"K Chauhan","year":"2014","unstructured":"Chauhan K, Sharma M, Trivedi P, Chaturvedi V, Chauhan PMS. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents. Bioorg Med Chem Lett. 2014;24:4166\u201370.","journal-title":"Bioorg Med Chem Lett"},{"key":"2281_CR45","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1016\/j.bmc.2013.06.067","volume":"21","author":"M Tukulula","year":"2013","unstructured":"Tukulula M, Njoroge M, Mugumbate GC, Gut J, Rosenthal PJ, Barteau S, et al. Tetrazole-based deoxyamodiaquines: synthesis, ADME\/PK profiling and pharmacological evaluation as potential antimalarial agents. Bioorg Med Chem. 2013;21:4904\u201313.","journal-title":"Bioorg Med Chem"},{"key":"2281_CR46","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1016\/j.bmcl.2014.07.061","volume":"24","author":"K Chauhan","year":"2014","unstructured":"Chauhan K, Sharma M, Trivedi P, Chaturvedi V, Chauhan PMS. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents. Bioorg Med Chem Lett. 2014;24:4166\u201370.","journal-title":"Bioorg Med Chem Lett"},{"key":"2281_CR47","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1039\/b102674g","volume":"1","author":"NCP Ara\u00fajo","year":"2002","unstructured":"Ara\u00fajo NCP, Barroca PMM, Bickley JF, Brigas AF, Cristiano MLS, Johnstone RAW, et al. Structural effects on sigmatropic shifts in heteroaromatic allyl ethers Electronic supplementary information (ESI) available: selected crystal data for compound 7. J Chem Soc Perkin Trans. 2002;1:1213\u20139.","journal-title":"J Chem Soc Perkin Trans"},{"key":"2281_CR48","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1021\/jp0517706","volume":"109","author":"A G\u00f3mez-Zavaglia","year":"2005","unstructured":"G\u00f3mez-Zavaglia A, Reva ID, Frija L, Cristiano ML, Fausto R. Molecular structure, vibrational spectra and photochemistry of 2-methyl-2H-tetrazol-5-amine in solid argon. J Phys Chem A. 2005;109:7967\u201376.","journal-title":"J Phys Chem A"},{"key":"2281_CR49","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/anie.201508104","volume":"55","author":"Z Li","year":"2016","unstructured":"Li Z, Qian L, Li L, Bernhammer JC, Huynh HV, Lee JS, et al. Tetrazole photoclick chemistry: reinvestigating its suitability as a bioorthogonal reaction and potential applications. Angew Chem Int Ed Engl. 2016;55:2002\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2281_CR50","doi-asserted-by":"publisher","first-page":"11656","DOI":"10.1021\/acs.joc.6b02023","volume":"81","author":"A Ismael","year":"2016","unstructured":"Ismael A, Fausto R, Cristiano MLS. Photochemistry of 1- and 2-methyl-5-aminotetrazoles: structural effects on reaction pathways. J Org Chem. 2016;81:11656\u201363.","journal-title":"J Org Chem"},{"key":"2281_CR51","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1039\/c1ob05088e","volume":"9","author":"I Fern\u00e1ndez","year":"2011","unstructured":"Fern\u00e1ndez I, Robert A. Peroxide bond strength of antimalarial drugs containing an endoperoxide cycle. Relation with biological activity. Org Biomol Chem. 2011;9:4098\u2013107.","journal-title":"Org Biomol Chem"},{"key":"2281_CR52","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1128\/AAC.01255-15","volume":"59","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wang Y, Cabrera M, Zhang Y, Gupta B, Wu Y, et al. Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene. Antimicrob Agents Chemother. 2015;59:6952\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"2281_CR54","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1128\/AAC.01924-13","volume":"58","author":"K Chotivanich","year":"2014","unstructured":"Chotivanich K, Tripura R, Das D, Yi P, Day NPJ, Pukrittayakamee S, et al. Laboratory detection of artemisinin-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 2014;58:3157\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR55","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"2281_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","volume":"12","author":"C Amaratunga","year":"2012","unstructured":"Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851\u20138.","journal-title":"Lancet Infect Dis."},{"key":"2281_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"2281_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12936-016-1148-2","volume":"15","author":"WA Kite","year":"2016","unstructured":"Kite WA, Melendez-Muniz VA, Moraes Barros RR, Wellems TE, S\u00e1 JM. Alternative methods for the Plasmodium falciparum artemisinin ring-stage survival assay with increased simplicity and parasite stage-specificity. Malar J. 2016;15:94.","journal-title":"Malar J."},{"key":"2281_CR59","doi-asserted-by":"publisher","first-page":"e01578","DOI":"10.1128\/AAC.01578-16","volume":"61","author":"N Thuy-Nhien","year":"2017","unstructured":"Thuy-Nhien N, Tuyen NK, Tong NT, Vy NT, Thanh NV, Van HT, et al. K13 propeller mutations in Plasmodium falciparum populations in regions of malaria endemicity in Vietnam from 2009\u20132016. Antimicrob Agents Chemother. 2017;61:e01578\u2013616.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12936-016-1569-y","volume":"15","author":"S Chaorattanakawee","year":"2016","unstructured":"Chaorattanakawee S, Lon C, Jongsakul K, Gawee J, Sok S, Sundrakes S, et al. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand. Malar J. 2016;15:519.","journal-title":"Malar J."},{"key":"2281_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41467-017-00207-1","volume":"8","author":"PM O\u2019Neill","year":"2017","unstructured":"O\u2019Neill PM, Amewu RK, Charman SA, Sabbani S, Gn\u00e4dig NF, Straimer J, et al. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance. Nat Commun. 2017;8:151\u20139.","journal-title":"Nat Commun."},{"key":"2281_CR62","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A Worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"2281_CR63","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1073\/pnas.1211205110","volume":"110","author":"S Takala-Harrison","year":"2013","unstructured":"Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA. 2013;110:240\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2281_CR64","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2015;211:670\u20139.","journal-title":"J Infect Dis"},{"key":"2281_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"2281_CR66","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","volume":"57","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.05456-11","volume":"56","author":"F Teuscher","year":"2012","unstructured":"Teuscher F, Chen N, Kyle DE, Gatton ML, Cheng Q. Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition. Antimicrob Agents Chemother. 2012;56:428\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"2281_CR68","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1021\/jm500075d","volume":"57","author":"A Paulo","year":"2014","unstructured":"Paulo A, Figueiras M, Machado M, Charneira C, Lavrado J, Santos SA, et al. Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities. J Med Chem. 2014;57:3295\u2013313.","journal-title":"J Med Chem"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2281-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T19:37:25Z","timestamp":1554233845000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2281-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2281-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"13 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"145"}}